Ardelyx (ARDX) Revenue (2013 - 2026)
Ardelyx's (ARDX) quarterly Revenue came in at $94.5 million in Q1 2026, up 27.47% YoY from $74.1 million in Q1 2025, and down 24.55% on a QoQ basis from $125.2 million in Q4 2025.
Ardelyx (ARDX) Revenue (2013 - 2026) Analysis & Trends
Ardelyx (ARDX) has 12 years of Revenue data on file, last reported at $94.5 million in Q1 2026.
- Quarterly Revenue rose 27.47% year-over-year to $94.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320.8 million (down 11.32% YoY) and the FY2025 annual result came in at $407.3 million, up 22.09% from the prior year.
- Revenue slipped to $94.5 million in Q1 2026, from $125.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $125.2 million in Q4 2025 to a low of $468000.0 in Q1 2022.
- A 5-year average of $53.2 million and a median of $46.0 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue soared 4193.29% — and 2025, when it plunged 96.54%.
- Tracing ARDX's Revenue over 5 years: stood at $44.2 million in 2022, then retreated by 22.22% to $34.4 million in 2023, then jumped by 237.95% to $116.1 million in 2024, then grew by 7.82% to $125.2 million in 2025, then fell by 24.55% to $94.5 million in 2026.
- The last three Revenue figures came in at $94.5 million (Q1 2026), $125.2 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 120.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120.88 Mn |
| Mar 31, 2026 | 94.47 Mn |
| Dec 31, 2025 | 125.22 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 97.66 Mn |
| Mar 31, 2025 | 74.11 Mn |
| Dec 31, 2024 | 116.13 Mn |
| Sep 30, 2024 | 98.24 Mn |
| Jun 30, 2024 | 73.22 Mn |
| Mar 31, 2024 | 46.02 Mn |
| Dec 31, 2023 | 34.36 Mn |
| Sep 30, 2023 | 56.39 Mn |
| Jun 30, 2023 | 22.33 Mn |
| Mar 31, 2023 | 11.37 Mn |
| Dec 31, 2022 | 44.18 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 468,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.17 Mn |